Meng Hao

Meng Hao

Auto-generated profile, based on publicly available information

Meng Hao

Department of Geriatric Medicine, Huadong Hospital, Shanghai Medical College Fudan University Shanghai 200040 China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Journal of Genetics and Genomics
Verified
Journal Article
Closed access
MHMeng Hao
Meng Hao
WPWeilin Pu
Weilin Pu
YLYi Li
Yi Li
SWShaoqing Wen
Shaoqing Wen
CSChang Sun
Chang Sun
LJLi Jin
Li Jin

10 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
FPFan Pu
Fan Pu
WCWeiran Chen
Weiran Chen
CLChenxi Li
Chenxi Li
JFJingqiao Fu
Jingqiao Fu
WGWeijing Gao
Weijing Gao
ZLZuyun Liu
Zuyun Liu
Complicated associations between multiplexed environmental factors and aging are poorly understood. We manipulated aging using multidimensional metrics such as phenotypic age, brain age, and brain volumes in the UK Biobank. Weighted quantile sum regression was used to examine the relative individual contributions of multiplexed environmental factors to aging, and self-organizing maps (SOMs) were used to examine joint effects. Air pollution presented a relatively large contribution in most cases. We also found fair heterogeneities in which the same environmental factor contributed inconsistently to different aging metrics. Particulate matter contributed the most to variance in aging, while noise and green space showed considerable contribution to brain volumes. SOM identified five subpopulations with distinct environmental exposure patterns and the air pollution subpopulation had the worst aging status. This study reveals the heterogeneous associations of multiplexed environmental factors with multidimensional aging metrics and serves as a proof of concept when analyzing multifactors and multiple outcomes.

2 July 2025 in Advanced Science
Verified
Journal Article
Open access
MHMeng Hao
Meng Hao
HZHui Zhang
Hui Zhang
JWJingyi Wu
Jingyi Wu
YHYaqi Huang
Yaqi Huang
XLXiangnan Li
Xiangnan Li
YLYi Li
Yi Li
Biological age reflects actual ageing and overall health, but current ageing clocks are often complex and difficult to interpret, which limits their clinical application. This study introduces a Gompertz law‐based biological age (GOLD BioAge) model designed to simplify the assessment of ageing. We calculated GOLD BioAge using clinical biomarkers and found significant associations between the difference from chronological age (BioAgeDiff) and the risks of morbidity and mortality in the NHANES and UK Biobank. Using proteomics and metabolomics data, we developed GOLD ProtAge and MetAge, which outperformed the clinical biomarker models in predicting mortality and chronic disease risk in UK Biobank. Benchmark analyses demonstrated that the models outperformed common ageing clocks in predicting mortality across diverse age groups in both the NHANES and UK Biobank cohorts. Additionally, a simplified version called Light BioAge is created, which uses three biomarkers to assess ageing. The Light model reliably captured the mortality risk across three validation cohorts (CHARLS, RuLAS, and CLHLS). It significantly predicted the onset of frailty, stratified frail individuals, and collectively identified individuals at high risk of mortality. In summary, the GOLD BioAge algorithm provides a valuable framework for the assessment of ageing in public health and clinical practice.

26 November 2021 in Aging Cell
Verified
Journal Article
Open access
PDF file
MHMeng Hao
Meng Hao
HZHui Zhang
Hui Zhang
ZHZixin Hu
Zixin Hu
XJXiaoyan Jiang
Xiaoyan Jiang
QSQi Song
Qi Song
LJLi Jin
Li Jin
Ageing is characterized by degeneration and loss of function across multiple physiological systems. To study the mechanisms and consequences of ageing, several metrics have been proposed in a hierarchical model, including biological, phenotypic and functional ageing. In particular, phenotypic ageing and interconnected changes in multiple physiological systems occur in all ageing individuals over time. Recently, phenotypic age, a new ageing measure, was proposed to capture morbidity and mortality risk across diverse subpopulations in US cohort studies. Although phenotypic age has been widely used, it may overlook the complex relationships among phenotypic biomarkers. Considering the correlation structure of these phenotypic biomarkers, we proposed a composite phenotype analysis (CPA) strategy to analyse 71 biomarkers from 2074 individuals in the Rugao Longitudinal Ageing Study. CPA grouped these biomarkers into 18 composite phenotypes according to their internal correlation, and these composite phenotypes were mostly consistent with prior findings. In addition, compared with prior findings, this strategy exhibited some different yet important implications. For example, the indicators of kidney and cardiovascular functions were tightly connected, implying internal interactions. The composite phenotypes were further verified through associations with functional metrics of ageing, including disability, depression, cognitive function and frailty. Compared to age alone, these composite phenotypes had better predictive performances for functional metrics of ageing. In summary, CPA could reveal the hidden relationships of physiological systems and identify the links between physiological systems and functional ageing metrics, thereby providing novel insights into potential mechanisms underlying human ageing.

3 October 2024 in Research Square
Verified
Preprint
Open access
PDF file
MHMeng Hao
Meng Hao
HZHui Zhang
Hui Zhang
YLYi Li
Yi Li
JWJingyi Wu
Jingyi Wu
ZHZixin Hu
Zixin Hu
XWXiaofeng Wang
Xiaofeng Wang
Background The American Heart Association (AHA) has introduced the cardiovascular-kidney-metabolic (CKM) syndrome as a systemic health disorder affecting nearly all organ systems. However, evidence supporting CKM syndrome health-related effects remains scarce, and its effects beyond its components are not studied. Methods Here, we used data from the China Health and Retirement Longitudinal Study (CHARLS) to investigate the associations of CKM syndrome with adverse health outcomes, including functional disability, physical frailty, falls, hospitalization and mortality. Then, we examined the associations between CKM syndrome and all-cause and cause-specific mortalityusing data from the US National Health and Nutrition Examination Survey (NHANES). Results CKM syndrome stages were independently associated with incident geriatric syndromes, including incident disability (OR, 1.2, [95% CI, 1.11-1.29]), frailty (OR, 1.28, [95% CI, 1.15-1.42]), falls (OR, 1.11, [95% CI, 1.06-1.17]), and hospitalization (OR, 1.19, [95% CI, 1.14-1.25]). Moreover, CKM syndrome stages independently predicted all-cause mortality (CHARLS: HR, 1.12 [95% CI, 1.06-1.18]; NHANES: HR, 1.34 [95% CI, 1.29-1.40]), and cause-specific mortality, including CVD (HR, 1.62, [95% CI, 1.50-1.75]), malignant neoplasm (HR, 1.20, [95% CI, 1.10-1.30]), respiratory disease (HR, 1.26, [95% CI, 1.07-1.49]). After adjusting for CKM components, the positive associations of CKM syndrome with geriatric syndrome and mortality were persisted, indicating that CKM syndrome has health implications beyond those of its component disorders. There were dose-effect relationships between CKM stages and risks of geriatric syndromes and mortality. Especially, advanced CKM syndrome (stage 3-4) exhibited higher risks of adverse outcomes along the CKM staging spectrum. Conclusion The findings revealed that CKM syndrome significantly impacted the overall health among middle-aged and older adults, advocating its application from CVD to geriatric community and multidiscipline clinical settings. It suggested the need for CKM syndrome assessment to predict and prevent geriatric syndromes and major chronic conditions, thereby reducing social and healthcare burdens. Moreover, these results provided empirical evidence for the validity and robustness of the CKM staging classification.

18 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
HZHui Zhang
Hui Zhang
MHMeng Hao
Meng Hao
CDChongyu Ding
Chongyu Ding
YXYaqian Xu
Yaqian Xu
ZHZixin Hu
Zixin Hu
XLXiangwei Li
Xiangwei Li
Background: Social participation is increasingly recognized as a modifiable determinant of healthy aging, but whether its forms confer differential survival benefits remains unclear. We aimed to examine the associations of domain-specific social participation with all‑cause mortality. Methods: This study used data from two nationally representative cohorts aged ≥ 60 years: the Chinese Longitudinal Healthy Longevity Survey (CLHLS, 2002–2018) with 13,911 participants, and the China Family Panel Studies (CFPS, 2010–2022) with 6,573 participants. Social participation was assessed and classified into community‑based and family‑based participation. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence interval (CIs). Findings: Family‑based participation was associated with a lower mortality risk in CLHLS (HR 0.66, 95% CI: 0.63–0.69) and CFPS (HR 0.53, 95% CI: 0·46–0.61), as was community‑based participation in CLHLS (HR 0.73, 95% CI: 0.70–0.76) and CFPS (HR 0.69, 95% CI: 0.62–0.77). In mutually adjusted models, the association with all-cause mortality was significantly stronger for family-based than for community-based participation in CFPS and CLHLS (both P-value < 0.05). Each additional participation domain was associated with progressively lower mortality risk in the CLHLS (HR 0.76, 95% CI: 0.74–0.78) and the CFPS (HR 0.66, 95% CI: 0.60–0.71). Interpretation: Social participation was independently associated with lower mortality risk, but the strength of association differed by domain type, with family‑based participation showing stronger benefits. A greater number of participation domains was associated with incrementally lower mortality risk.